Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter"

Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter" / G. Murgia, C.A. Maronese, C.G. Carrera, A. Cattaneo, A.V. Marzano. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 35:8(2022 Aug), pp. e15644.1-e15644.3. [Epub ahead of print] [10.1111/dth.15644]